Download Citation
Article Source:
Effectiveness and safety of weekly paclitaxel and cetuximab as a salvage chemotherapy following immune checkpoint inhibitors for recurrent or metastatic head and neck squamous cell carcinoma: A multicenter clinical study
Wakasaki T,
Manako T,
Yasumatsu R,
Hara H,
Toh S,
et al.
(2022)
Effectiveness and safety of weekly paclitaxel and cetuximab as a salvage chemotherapy following immune checkpoint inhibitors for recurrent or metastatic head and neck squamous cell carcinoma: A multicenter clinical study.
PLOS ONE 17(7): e0271907.
https://doi.org/10.1371/journal.pone.0271907